- 专利标题： Heterocyclic compound and use thereof
-
申请号： US16052967申请日： 2018-08-02
-
公开(公告)号： US10428023B2公开(公告)日： 2019-10-01
- 发明人: Yuichi Kajita , Yuhei Miyanohana , Tatsuki Koike , Kohei Takeuchi , Yoshiteru Ito , Norihito Tokunaga , Takahiro Sugimoto , Tohru Miyazaki , Tsuneo Oda , Yasutaka Hoashi , Yasushi Hattori , Keisuke Imamura
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Foley & Lardner LLP
- 优先权： JP2017-150685 20170803; JP2017-248495 20171225
- 主分类号： C07D211/56
- IPC分类号： C07D211/56 ; A61P25/00 ; C07D205/04 ; C07D207/14 ; C07D401/06 ; C07D401/10 ; C07D401/14 ; C07D403/06 ; C07D405/10 ; C07D405/12 ; C07D413/06 ; C07D417/06 ; C07D417/14 ; C07D405/06 ; C07D211/36
摘要：
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
公开/授权文献
- US20190040010A1 HETEROCYCLIC COMPOUND AND USE THEREOF 公开/授权日：2019-02-07
信息查询
